ConductScience.org, home

Paper41398960

The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist.

Papavergi MT and 3 others. Mol Neurodegener, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist. Papers, record 41398960. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398960

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist.
PubMed
Journal
Mol Neurodegener
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.89, provisional
iCite
Revised in PubMed
2026-09-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Papavergi MTMaria-Tzousi
2Bathini PPraveen
3Singh BBrijendra
4Lemere CACynthia A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Complement System ProteinsMajor topic
Complement ActivationMajor topic
Humans
Animals
Brain

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 NS136122NINDS NIH HHSUnited StatesR01NS136122PubMed

Source NIH RePORTER

Download CSV of grants

References448

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139871402Physical Exercise Decreases Complement-Mediated Synaptic Loss and Protects Against Cognitive Impairment by Inhibiting Microglial Tmem9-ATP6V0D1 in Alzheimer's Disease.Aging Cell2025https://conductscience.org/library/papers/39871402PubMed
226243271CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease.Neuropsychopharmacology2016https://conductscience.org/library/papers/26243271PubMed
327554295Mechanisms of inflammation-driven bacterial dysbiosis in the gut.Mucosal Immunol2017https://conductscience.org/library/papers/27554295PubMed
424038819Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies.Am J Med Genet B Neuropsychiatr Genet2013https://conductscience.org/library/papers/24038819PubMed
537865470Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.Lancet2023https://conductscience.org/library/papers/37865470PubMed
633423792Blood-Brain Barrier Dynamics to Maintain Brain Homeostasis.Trends Neurosci2021https://conductscience.org/library/papers/33423792PubMed
731060348miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.Eur J Histochem2019https://conductscience.org/library/papers/31060348PubMed
829134267Complement in the pathogenesis of Alzheimer's disease.Semin Immunopathol2018https://conductscience.org/library/papers/29134267PubMed
929051531Gut microbiome alterations in Alzheimer's disease.Sci Rep2017https://conductscience.org/library/papers/29051531PubMed
1025727254Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.Ann Neurol2015https://conductscience.org/library/papers/25727254PubMed
1117942002Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areas.BMC Genet2007https://conductscience.org/library/papers/17942002PubMed
1239009837A clinical perspective on the revised criteria for diagnosis and staging of Alzheimer's disease.Nat Aging2024https://conductscience.org/library/papers/39009837PubMed
1324566914Intestinal epithelial cells: regulators of barrier function and immune homeostasis.Nat Rev Immunol2014https://conductscience.org/library/papers/24566914PubMed
1439789340Human iPSC-derived microglial cells protect neurons from neurodegeneration in long-term cultured adhesion brain organoids.Commun Biol2025https://conductscience.org/library/papers/39789340PubMed
1539147742C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model.Nat Commun2024https://conductscience.org/library/papers/39147742PubMed
1640050704Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease.Nat Med2025https://conductscience.org/library/papers/40050704PubMed
1735336153Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options.Microorganisms2022https://conductscience.org/library/papers/35336153PubMed
1822244847Alzheimer's disease risk factor complement receptor 1 is associated with depression.Neurosci Lett2012https://conductscience.org/library/papers/22244847PubMed
1923482636Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.FASEB J2013https://conductscience.org/library/papers/23482636PubMed
2018801740An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.J Biol Chem2008https://conductscience.org/library/papers/18801740PubMed

See all 448 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42918974Gut-brain axis in Alzheimer's disease: neuroinflammatory mechanisms and immunopharmacological interventions.Inflammopharmacology2026https://conductscience.org/library/papers/42918974PubMed
42877317Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877317PubMed
42796561Small-Molecule NANT Therapeutics Targeting the Brain-Immune Axis in Alzheimer's Disease: Mechanisms, Clinical Progress, and Translational Challenges.Molecules2026https://conductscience.org/library/papers/42796561PubMed
42712875Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease.Alzheimers Dement (N Y)2026https://conductscience.org/library/papers/42712875PubMed
42667495Integrative transcriptomics identifies shared aging-associated inhibitory-neuron states and prioritizes RGL2 across postoperative delirium and Alzheimer's disease.J Mol Neurosci2026https://conductscience.org/library/papers/42667495PubMed
42363270Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice.Mol Neurodegener2026https://conductscience.org/library/papers/42363270PubMed
42337797The complement system in Alzheimer's disease: evaluating biomarker potential in a complex neuroimmune context.J Neuroinflammation2026https://conductscience.org/library/papers/42337797PubMed
42064068The complement system in Alzheimer's disease: mechanisms, biomarkers, and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42064068PubMed
41867862Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice.bioRxiv2026https://conductscience.org/library/papers/41867862PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41398960

GET https://conductscience.org/api/papers/v1/41398960/references?page=2